Kinase Inhibitors from Marine Natural Products
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (1 October 2020) | Viewed by 384
Special Issue Editor
Interests: marine natural products; marine biotechnology, marine algae; anti-oxidant; anti-HIV; Anti-cancer; anti-allergy; anti-inflammation; marine cosmeceuticals; nutraceuticals and pharmaceuticals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Seventy percent of the Earth’s surface is covered by oceans, which are home to more than seventy percent of living organisms. Sponges, algae, fish species, microorganisms, crustaceans, sea cucumbers, and corals are some of them. These species are resources for potential drugs used for treating various diseases. These organisms are living in extreme conditions, such as different salinity, and lack of nutrients and sunlight; therefore, they can produce potential secondary metabolites. The metabolites/compounds can range from polyphenols, alkaloids, terpenoids, steroids, proteins, lipids, polysaccharides, etc. These compounds can be used as kinase inhibitors and as a cure for several diseases, including the most common and deadly disease—cancer. After finding the metabolic pathways regulating diseases, these kinase inhibitors derived from marine origin molecules can be potentially used to treat several diseases that are involved in protein and lipid kinases.
Prof. Se-Kwon Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- kinase inhibitors
- anticancer drugs
- chronic inflammation
- tumor treatment
- psoriasis
- rheumatoid arthritis
- lung cancer
- macular degeneration
- thyroid cancer
- breast cancer
- renal cell carcinoma
- hypertension
- central nerve system diseases
- Parkinson’s disease, Alzheimer’s disease, and corneal endothelial diseases
